Thyroid Cancer Trial, Recruiting NCT06800768 Sponsor: Ruijin Hospital Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT06800768
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with thyroid cancer, have had surgery, and doctors currently suspect the cancer may have come back or spread to other parts of the body.
  • You are willing and able to sign and date a consent form agreeing to take part.
  • You are willing to follow all the study procedures and take part in the full research process.
  • You are between 18 and 80 years old.

Who may not be able to join:

  • You have a serious illness that the research team feels makes it unsafe for you to participate, such as severe heart or lung failure, severely reduced bone marrow function, or severe liver or kidney problems.
  • You have a hole in your intestine (intestinal perforation) or a complete blockage of your intestine.
  • You are pregnant, think you might be pregnant, or you are currently breastfeeding.
  • You are unable or unlikely to follow the study's requirements and procedures.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13524945287

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
31 January 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnosis of recurrent or metastatic thyroid cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov